No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Benzamides
-
Biomarkers, Tumor / blood
-
Cytarabine / therapeutic use
-
Fusion Proteins, bcr-abl / blood*
-
Genes, abl
-
Humans
-
Imatinib Mesylate
-
Interferon-alpha / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Piperazines / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Reverse Transcriptase Polymerase Chain Reaction
-
Transcription, Genetic
Substances
-
Antineoplastic Agents
-
Benzamides
-
Biomarkers, Tumor
-
Interferon-alpha
-
Piperazines
-
Pyrimidines
-
Cytarabine
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl